Global Drug Discovery Services Market Forecast 2026–2036: Market Expansion Driven by Externalized R&D
The global drug discovery services market is projected to witness strong expansion over the next decade, supported by an accelerating shift toward externalized research and development (R&D) models and declining internal productivity. The market is expected to grow steadily, reaching approximately USD 117,163.1 Million by 2036, registering a CAGR of 14.7%, according to the latest analysis by Future Market Insights (FMI). Market growth is being shaped by increasing pharmaceutical R&D expenditure, rising demand for biologics, and the rapid adoption of advanced computational technologies. Drug discovery workflows have evolved from traditional wet-lab-only processes into sophisticated hybrid pipelines. While small-molecule research continues to anchor a vast portion of the field, pharmaceutical and biotechnology companies are increasingly integrating artificial intelligence (AI), machine learning, and high-dimensional experimentation to reduce development cycles and lower d...